In conclusion, our data support the concept of using FIASMAs to simultaneously overactivate autophagy and induce LMP in order to target two potential Achilles heels of GBM, i.e., lysosomal function and lipid trafficking as a novel strategy for the treatment of GBM. Here, PDLIM7 is linked to glioblastoma.